- €1.08bn
- €3.13bn
- €2.32bn
Brief: Gerresheimer AG - Reschedules Publication Of 2025 Financial Statements And Initiates Sale Of Centor Inc
Brief: Gerresheimer To Correct All Revenues From Bill-And-Hold Agreements Recognized In 2024 Financial Statements In Amount Of EUR 28M
Brief: Societe Generale SA Holds 5.07% Of Total Voting Rights And Instruments In Gerresheimer AG As Of Dec 1
BNP picks medtech favourites, sees re-rating in H2 2026
Gerresheimer falls after Morpheus reveals short position
Brief: Morpheus Research - Short Gerresheimer AG
Brief: STOXX Ltd. Announces December 2025 Review Results Of DAX Indices
Brief: Gerresheimer - Klaus Roehrig Succeeds Dorothea Wenzel On Supervisory Board
Gerresheimer appoints Roehrhoff as interim CEO (updated)
Gerresheimer appoints Uwe Röhrhoff as new interim CEO
Brief: Gerresheimer New Formation Of The Management Board
Brief: Uwe Röhrhoff Takes Over As Interim CEO For Dietmar Siemssen
Europe Research Roundup: Dassault Systemes, Fuchs, Nokia
Gerresheimer finds 2024 revenue-recognition issues after external probe
Brief: Gerresheimer AG Says Initial Findings Of An External Independent Investigation Into Revenue Recognition From Bill-And-Hold Agreements In The 2024 Financial Year
Europe Research Roundup: Aryzta, Secunet Security Networks, Whitbread
Europe Research Roundup: Adidas, LVMH, Mercedes-Benz Group
Europe Research Roundup: Adidas, Mercedes-Benz Group, VAT Group
Brief: FDA Approves Gerresheimer's SQ Innovation's Lasix Onyu